Trial intelligence / Profile preview

Eskata Satisfaction Study for Seborrheic Keratoses

NCT03487588Phase 4Completed

Sponsor
Aclaris Therapeutics, Inc.
Start
Mar 2018
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of hydrogen peroxide gel in seborrheic keratosis (SK), sponsored by Aclaris Therapeutics, Inc.. Started Mar 2018; status: completed.

02

Drugs

hydrogen peroxide gel
03

Conditions

seborrheic keratosis (SK)

Beyond the preview

Go deeper on NCT03487588.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03487588.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call